日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

EGFR扩增与晚期胃食管癌患者接受单纯化疗或化疗联合帕尼单抗治疗的随机III期试验结果

Smyth, Elizabeth C; Vlachogiannis, Georgios; Hedayat, Somaieh; Harbery, Alice; Hulkki-Wilson, Sanna; Salati, Massimiliano; Kouvelakis, Kyriakos; Fernandez-Mateos, Javier; Cresswell, George D; Fontana, Elisa; Seidlitz, Therese; Peckitt, Clare; Hahne, Jens C; Lampis, Andrea; Begum, Ruwaida; Watkins, David; Rao, Sheela; Starling, Naureen; Waddell, Tom; Okines, Alicia; Crosby, Tom; Mansoor, Was; Wadsley, Jonathan; Middleton, Gary; Fassan, Matteo; Wotherspoon, Andrew; Braconi, Chiara; Chau, Ian; Vivanco, Igor; Sottoriva, Andrea; Stange, Daniel E; Cunningham, David; Valeri, Nicola

Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine

AKT抑制剂及其相关预测性生物标志物的临床开发,旨在指导癌症患者的治疗

Coleman, Niamh; Moyers, Justin T; Harbery, Alice; Vivanco, Igor; Yap, Timothy A